Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio
Medicxi Ventures Management (Jersey) Ltd Performance:
2025 Q4: 12.17%YTD: 42.99%2024: 74.69%
Performance for 2025 Q4 is 12.17%, and YTD is 42.99%, and 2024 is 74.69%.
About Medicxi Ventures Management (Jersey) Ltd and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $835 Millions as of 31 Dec, 2025.
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, PHAT, NAMS. The fund has invested 59.8% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 14.8% of portfolio in PHATHOM PHARMACEUTICALS INC .
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, PHAT, NAMS. The fund has invested 59.8% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 14.8% of portfolio in PHATHOM PHARMACEUTICALS INC .
Medicxi Ventures Management (Jersey) Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Medicxi Ventures Management (Jersey) Ltd made a return of 12.17% in the last quarter. In trailing 12 months, it's portfolio return was 42.99%.
- Performance
- S&P 500
New Buys
Additions
Reductions
Sold off
Sector Distribution
Medicxi Ventures Management (Jersey) Ltd has about 100% of it's holdings in Healthcare sector.
- Healthcare
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
Medicxi Ventures Management (Jersey) Ltd has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 76.6 |
| UNALLOCATED | 12.1 |
| MICRO-CAP | 11.3 |
Stocks belong to which Index?
About 28.1% of the stocks held by Medicxi Ventures Management (Jersey) Ltd either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 71.9 |
| RUSSELL 2000 | 28.1 |
Medicxi Ventures Management (Jersey) Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd has 5 stocks in it's portfolio. AURA proved to be the most loss making stock for the portfolio. PHAT was the most profitable stock for Medicxi Ventures Management (Jersey) Ltd last quarter.
Last Reported on: 23 Jan, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AURA | aura biosciences inc | 1.98 | 3,039,890 | 16,567,400 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 59.80 | 19,963,200 | 499,279,000 | unchanged | 0.00 | ||
| NAMS | newamsterdam pharma company | 12.06 | 2,869,560 | 100,664,000 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 14.83 | 7,464,570 | 123,837,000 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 11.33 | 2,794,000 | 94,632,800 | unchanged | 0.00 | ||